Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Accounts Payables: 2019-2022

Historic Accounts Payables for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $12.4 million.

  • ADC Therapeutics' Accounts Payables fell 22.69% to $9.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.0 million, marking a year-over-year decrease of 22.69%. This contributed to the annual value of $12.4 million for FY2022, which is 2.24% up from last year.
  • According to the latest figures from FY2022, ADC Therapeutics' Accounts Payables is $12.4 million, which was up 2.24% from $12.1 million recorded in FY2021.
  • ADC Therapeutics' Accounts Payables' 5-year high stood at $12.4 million during FY2022, with a 5-year trough of $3.3 million in FY2019.
  • Over the past 2 years, ADC Therapeutics' median Accounts Payables value was $12.2 million (recorded in 2021), while the average stood at $12.2 million.
  • Data for ADC Therapeutics' Accounts Payables shows a peak YoY increased of 2.24% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows ADC Therapeutics' Accounts Payables stood at $3.3 million in 2019, then reached $12.1 million in 2021, then rose by 2.24% to $12.4 million in 2022.